Our Clinical Trials
- ACCESS-AP: A Case-Crossover Study design to inform tailored interventions to prevent disease progression in Acute Pancreatitis
- PAPPEI: Post-Acute Pancreatitis Pancreatic Exocrine Insufficiency
- SVI: Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis
- CalciMedica CM4620-203: Acute Pancreatitis Study
- PROCEED: Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
- SHARP: SpHincterotomy for Acute Recurrent Pancreatitis
- POST: A Prospective Observational Study of TPIAT
- DETECT: Evaluation of a mixed meal test for Diagnosis and characterization of Type 3c diabetes mellitus secondary to pancreatic cancer and chronic pancreatitis
- CAMOSTAT: A phase ½ trial to evaluate the pharmacokinetics, safety and efficacy of NI-03 in patients with chronic pancreatitis
- PAIR: Phase ½ trial of Indomethacin in Chronic Pancreatitis
- CLIMB: Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
- NANOPAC: Evaluation of Escalating Doses and the Safety of Intracystic Injection of NanoPac in Subjects with Cystic Pancreatic Neoplasms
- Pancreatic Cystic Fluid Reference Set: Evaluation of molecular markers in pancreatic cysts
- EQuiPP: Endoscopic Therapy on Quality of Life and Pain in Chronic Pancreatitis
- Pancreatic disorder repository: Biobank specimen repository